{
  "abstract": "Background: Cancer stem cells (CSCs) are a major contributor to breast cancer recurrence and therapeutic resistance. This study investigates the oncogenic role of Retinoblastoma Binding Protein 5 (RBBP5) in driving CSC-like properties in breast cancer.\n\nMethods: Genetic alterations in RBBP5 and their correlation with patient survival were analyzed using multiple breast cancer cohorts, including METABRIC, TCGA, and Kaplan-Meier (KM) plotter datasets. The impact of RBBP5 on CSC-like traits was assessed through tumorsphere formation and ALDEFLUOR assays, and in vivo xenograft models. To elucidate the underlying molecular mechanism, RNA sequencing (RNA-seq) was performed.\n\nResults: Elevated RBBP5 expression was significantly associated with poor prognosis in breast cancer. (METABRIC: OS, p = 0.007; DFS, p = 0.049; TCGA: OS, p < 0.001; KM plotter: RFS, p < 0.001). RBBP5 overexpression enhanced tumorsphere-forming capacity, CSC-like population and tumor-initiating cell frequency. RNA-seq results revealed an enrichment of gene sets associated with negative regulation of cell growth, invasiveness, and stem cell population in RBBP5-knockdown cells. RBBP5 knockdown upregulated WNT5A, a non-canonical Wnt ligand, leading to Hippo pathway activation and subsequent suppression of YAP signaling. Pharmacological inhibition of YAP1 abrogated RBBP5-induced CSC-like properties, while suppression of MST1/2 in RBBP5-knockdown cells restored YAP activity and CSC traits.\n\nConclusions: These findings indicate that RBBP5 promotes CSC-like properties in breast cancer by repressing WNT5A-mediated Hippo signaling. We suggest RBBP5 as a potential biomarker for poor prognosis and propose that targeting YAP or activating the Hippo pathway could represent a promising therapeutic approach for patients with RBBP5-overexpressing tumors.",
  "abstract_shown": true,
  "affiliations": [
    "Department of HY-KIST Bio-convergence, College of Medicine, Hanyang University, Seoul, Republic of Korea",
    "Department of Pathology, College of Medicine, Hanyang University, Seoul, Republic of Korea"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 3,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "So-Jeong Moon",
      "orcid": "0000-0002-6247-0855"
    },
    {
      "affs": [
        0
      ],
      "name": "Young-Hyeon Kye",
      "orcid": "0009-0009-1242-0807"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Gu Kong",
      "orcid": "0000-0001-9206-8210"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/ahd26j3mghdbf.bib",
  "cited_by": 0,
  "doi": "10.1080/15384047.2026.2756150",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13757685/",
  "id": "ahd26j3mghdbf",
  "issns": [
    "1538-4047",
    "1555-8576"
  ],
  "landing_url": "https://doi.org/10.1080/15384047.2026.2756150",
  "language": "en",
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Research Article"
    ],
    [
      "openalex",
      "1307|Hippo pathway signaling and YAP/TAZ"
    ]
  ],
  "openalex": "W7225464485",
  "pdf_url": "https://www.tandfonline.com/doi/pdf/10.1080/15384047.2026.2756150?needAccess=true",
  "pmcid": "PMC13757685",
  "pmid": "42998019",
  "published": "2026-11-07",
  "publisher": "Taylor & Francis",
  "ris": "https://research.draconitic.com/paper/ahd26j3mghdbf.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:23:16Z",
      "native_id": "PMC13757685",
      "source": "pmc",
      "url": "https://doi.org/10.1080/15384047.2026.2756150"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "openalex:1307|Hippo pathway signaling and YAP/TAZ",
      "subfield": "cell-biology"
    }
  ],
  "title": "RBBP5 drives cancer stem cell-like characteristics by suppressing the hippo signaling pathway through WNT5A downregulation in breast cancer",
  "title_text": "RBBP5 drives cancer stem cell-like characteristics by suppressing the hippo signaling pathway through WNT5A downregulation in breast cancer",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:23:16Z",
  "url": "https://research.draconitic.com/paper/ahd26j3mghdbf",
  "venue": "Cancer Biology & Therapy",
  "versions": []
}